WavoDyne Therapeutics
2014
FOUNDED
OOB
STATUS
1-10
EMPLOYEES
Out of Business
LATEST DEAL TYPE
Description
Developer of therapeutic treatments designed to help patients suffering from memory impairment. The company's treatments include the development of drugs for memory and cognitive disorders resulting from neuroinflammatory processes, enabling patients to get advanced therapy for their disorders and recover faster.
Website
Formerly Known As
Camber NeuroTheraputics
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- Lennox Tech Enterprise Center, 150 Lucius Gordon Drive
- Suite 100
- Rochester, NY 14586
- United States
+1 (954) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore WavoDyne Therapeutics’s full profile, request a free trial.
WavoDyne Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 20-Dec-2017 | Completed | Out of Business | |||
| 3. Early Stage VC | Completed | Startup | ||||
| 2. Angel (individual) | 01-Nov-2015 | $50K | Cancelled | Startup | ||
| 1. Grant | 31-Dec-2014 | $32.4M | Completed | Startup |
WavoDyne Therapeutics Executive Team (1)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Jim New Ph.D | Founder, Chief Executive Officer & Chairman |
WavoDyne Therapeutics Board Members (5)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| David Klein | Self | Board Member | 000 0000 | |
| Jim New Ph.D | WavoDyne Therapeutics | Founder, Chief Executive Officer & Chairman | 000 0000 | |
| Joseph Vacca Ph.D | Self | Board Member | 000 0000 | |
| Karl Kieburtz MD | Self | Board Member | 000 0000 |
1 Former Board Member
You’re viewing 4 of 5 board members. Get the full list »